Bellevue Group Ag Nuvasive Inc Transaction History

Bellevue Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$43.41 - $56.51 $3.56 Million - $4.64 Million	-82,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$47.43 - $60.75 $739,908 - $947,700	15,600 Added 23.46%	82,100 $3.99 Million
Q2 2020 Aug 13, 2020	BUY	$43.51 - $66.59 $2.89 Million - $4.43 Million	66,500 New	66,500 $3.7 Million
Q2 2018 Aug 07, 2018	SELL	$48.15 - $56.68 $1.56 Million - $1.83 Million	-32,312 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $702,657 - $844,494	-13,892 Reduced 30.07%	32,312 $1.89 Million
Q3 2017 Nov 13, 2017	BUY	$53.54 - $68.0 $583,586 - $741,200	10,900 Added 30.87%	46,204 $2.56 Million
Q2 2017 Aug 14, 2017	BUY	N/A	35,304	35,304 $2.72 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.